FDAFDA · Food and drugs·Recall number D-0341-2024
Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01
Published February 28, 2024 · Recall initiated: February 6, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TERLIVAZ
- Manufacturer
- Mallinckrodt Hospital Products Inc.
- Distributor
- USA nationwide
- Lot
- Lot #: 22TRP01-F2, Exp 6/30/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.